IMPAIRMENT OF INVITRO IMMUNE-RESPONSES OCCURS WITHIN 3 MONTHS AFTER HIV-1 SEROCONVERSION

被引:44
作者
TEEUWSEN, VJP
SIEBELINK, KHJ
DEWOLF, F
GOUDSMIT, J
UYTDEHAAG, FGCM
OSTERHAUS, ADME
机构
[1] NATL INST PUBL HLTH & ENVIRONM PROTECT, DEPT IMMUNOBIOL, POB 1, 3720 BA BILTHOVEN, NETHERLANDS
[2] MUNICIPAL HLTH SERV, DEPT INFECT DIS, AMSTERDAM, NETHERLANDS
[3] UNIV AMSTERDAM, DEPT MED VIROL, AMSTERDAM, NETHERLANDS
关键词
HIV-1; seroconversion; In vitro secondary immune response; Male homosexuals;
D O I
10.1097/00002030-199001000-00011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In a previous study we have shown that peripheral blood mononuclear cells (PBMC) from asymptomatic HIV-seropositive male homosexuals, who had seroconverted more than 2 years before, were unable to mount a secondary response in vitro to certain viral and bacterial antigens. We have extended this study by investigating the secondary immune responses of five male homosexuals, who, by regular screening, were found to have seroconverted for HIV-1 during the preceding 3 months and were subsequently vaccinated with tetanus toxoid and poliovirus vaccine. Six weeks after the booster vaccination, PBMC of the five recently seroconverted individuals were assayed for in vitro mitogen or recall antigen-induced antibody synthesis and lymphocyte proliferation. The results of this study indicate that certain of the in vitro abnormalities of immune reactions, observed in both symptomatic and asymptomatic HIV-seropositive individuals, can already be found within 3 months after seroconversion.
引用
收藏
页码:77 / 81
页数:5
相关论文
共 36 条
[1]   HIV-MEDIATED IMMUNODEPRESSION - INVITRO INHIBITION OF LYMPHOCYTE-T PROLIFERATIVE RESPONSE BY ULTRAVIOLET-INACTIVATED VIRUS [J].
AMADORI, A ;
FAULKNERVALLE, GP ;
DEROSSI, A ;
ZANOVELLO, P ;
COLLAVO, D ;
CHIECOBIANCHI, L .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 46 (01) :37-54
[2]   SPONTANEOUS INVITRO PRODUCTION OF VIRUS-SPECIFIC ANTIBODY BY LYMPHOCYTES FROM HIV-INFECTED SUBJECTS [J].
AMADORI, A ;
DEROSSI, A ;
FAULKNERVALLE, GP ;
CHIECOBIANCHI, L .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 46 (03) :342-351
[3]  
BURKES RL, 1987, CANCER-AM CANCER SOC, V59, P731, DOI 10.1002/1097-0142(19870215)59:4<731::AID-CNCR2820590412>3.0.CO
[4]  
2-5
[5]   CHARACTERIZATION OF LYMPHOCYTE-T RESPONSES DURING PRIMARY INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS [J].
COOPER, DA ;
TINDALL, B ;
WILSON, EJ ;
IMRIE, AA ;
PENNY, R .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (05) :889-896
[6]   ANALYSIS OF ABSOLUTE T-HELPER CELL NUMBER AND CELLULAR IMMUNE DEFECTS IN HIV ANTIBODY POSITIVE AND NEGATIVE HOMOSEXUAL MEN [J].
CREEMERS, PC ;
OSHAUGHNESSY, M ;
BOYKO, WJ .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1988, 4 (04) :269-278
[7]  
DEWOLF F, 1988, J INFECT DIS, V158, P615, DOI 10.1093/infdis/158.3.615
[8]   THE RELATIONSHIP OF ABNORMALITIES OF CELLULAR-IMMUNITY TO ANTIBODIES TO HTLV-III IN HOMOSEXUAL MEN [J].
DOBOZIN, BS ;
JUDSON, FN ;
COHN, DL ;
PENLEY, KA ;
RICKMANN, PE ;
BLASER, MJ ;
SARIN, PS ;
WEISS, SH ;
KIRKPATRICK, CH .
CELLULAR IMMUNOLOGY, 1986, 98 (01) :156-171
[9]  
DOMOK I, 1979, WHO OFFSET PUBL, V13, P1
[10]   THE HUMAN IMMUNODEFICIENCY VIRUS - INFECTIVITY AND MECHANISMS OF PATHOGENESIS [J].
FAUCI, AS .
SCIENCE, 1988, 239 (4840) :617-622